National prevalence of IC/BPS in women and men utilizing veterans health administration data

ImportanceInterstitial cystitis/bladder pain syndrome (IC/BPS) is an immense burden to both patients and the American healthcare system; it is notoriously difficult to diagnose. Prevalence estimates vary widely (150-fold range in women and >500-fold range in men).ObjectivesWe aimed to create...

Full description

Bibliographic Details
Main Authors: Jennifer T. Anger, Kai B. Dallas, Catherine Bresee, Amanda M. De Hoedt, Kamil E. Barbour, Katherine J. Hoggatt, Marc T. Goodman, Jayoung Kim, Stephen J. Freedland
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pain Research
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpain.2022.925834/full
_version_ 1818496308567080960
author Jennifer T. Anger
Kai B. Dallas
Catherine Bresee
Amanda M. De Hoedt
Kamil E. Barbour
Katherine J. Hoggatt
Marc T. Goodman
Jayoung Kim
Jayoung Kim
Stephen J. Freedland
Stephen J. Freedland
Stephen J. Freedland
author_facet Jennifer T. Anger
Kai B. Dallas
Catherine Bresee
Amanda M. De Hoedt
Kamil E. Barbour
Katherine J. Hoggatt
Marc T. Goodman
Jayoung Kim
Jayoung Kim
Stephen J. Freedland
Stephen J. Freedland
Stephen J. Freedland
author_sort Jennifer T. Anger
collection DOAJ
description ImportanceInterstitial cystitis/bladder pain syndrome (IC/BPS) is an immense burden to both patients and the American healthcare system; it is notoriously difficult to diagnose. Prevalence estimates vary widely (150-fold range in women and >500-fold range in men).ObjectivesWe aimed to create accurate national IC/BPS prevalence estimates by employing a novel methodology combining a national population-based dataset with individual chart abstraction.Study designIn this epidemiological survey, all living patients, with ≥2 clinic visits from 2016 to 2018 in the Veterans Health Administration, with an ICD-9/10 code for IC/BPS (n = 9,503) or similar conditions that may represent undiagnosed IC/BPS (n = 124,331), were identified (other were controls n = 5,069,695). A detailed chart review of random gender-balanced samples confirmed the true presence of IC/PBS, which were then age- and gender-matched to the general US population.ResultsOf the 5,203,529 patients identified, IC/BPS was confirmed in 541 of 1,647 sampled charts with an IC/BPS ICD code, 10 of 382 charts with an ICD-like code, and 3 of 916 controls. After age- and gender-matching to the general US population, this translated to national prevalence estimates of 0.87% (95% CI: 0.32, 1.42), with female and male prevalence of 1.08% (95% CI: 0.03, 2.13) and 0.66% (95% CI: 0.44, 0.87), respectively.ConclusionsWe estimate the prevalence of IC/BPS to be 0.87%, which is lower than prior estimates based on survey data, but higher than prior estimates based on administrative data. These potentially represent the most accurate estimates to date, given the broader and more heterogeneous population studied and our novel methodology of combining in-depth chart abstraction with administrative data.
first_indexed 2024-12-10T18:31:43Z
format Article
id doaj.art-9d5175f5abaf4654a486fdc7321304b9
institution Directory Open Access Journal
issn 2673-561X
language English
last_indexed 2024-12-10T18:31:43Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pain Research
spelling doaj.art-9d5175f5abaf4654a486fdc7321304b92022-12-22T01:37:56ZengFrontiers Media S.A.Frontiers in Pain Research2673-561X2022-08-01310.3389/fpain.2022.925834925834National prevalence of IC/BPS in women and men utilizing veterans health administration dataJennifer T. Anger0Kai B. Dallas1Catherine Bresee2Amanda M. De Hoedt3Kamil E. Barbour4Katherine J. Hoggatt5Marc T. Goodman6Jayoung Kim7Jayoung Kim8Stephen J. Freedland9Stephen J. Freedland10Stephen J. Freedland11Department of Urology, UC San Diego Health, San Diego, CA, United StatesCity of Hope Urology, Duarte, CA, United StatesDepartment of Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, United StatesUrology Section, Department of Surgery, Veterans Affairs Medical Centers Division of Population Health, Durham, NC, United StatesNational Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United StatesCenter for Study of Healthcare Implementation, Innovation and Policy Veterans Health Administration, Los Angeles, CA, United StatesCedars-Sinai Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United StatesCedars-Sinai Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United StatesDepartment of Surgery and Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, United StatesUrology Section, Department of Surgery, Veterans Affairs Medical Centers Division of Population Health, Durham, NC, United StatesCedars-Sinai Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United StatesDepartment of Surgery and Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA, United StatesImportanceInterstitial cystitis/bladder pain syndrome (IC/BPS) is an immense burden to both patients and the American healthcare system; it is notoriously difficult to diagnose. Prevalence estimates vary widely (150-fold range in women and >500-fold range in men).ObjectivesWe aimed to create accurate national IC/BPS prevalence estimates by employing a novel methodology combining a national population-based dataset with individual chart abstraction.Study designIn this epidemiological survey, all living patients, with ≥2 clinic visits from 2016 to 2018 in the Veterans Health Administration, with an ICD-9/10 code for IC/BPS (n = 9,503) or similar conditions that may represent undiagnosed IC/BPS (n = 124,331), were identified (other were controls n = 5,069,695). A detailed chart review of random gender-balanced samples confirmed the true presence of IC/PBS, which were then age- and gender-matched to the general US population.ResultsOf the 5,203,529 patients identified, IC/BPS was confirmed in 541 of 1,647 sampled charts with an IC/BPS ICD code, 10 of 382 charts with an ICD-like code, and 3 of 916 controls. After age- and gender-matching to the general US population, this translated to national prevalence estimates of 0.87% (95% CI: 0.32, 1.42), with female and male prevalence of 1.08% (95% CI: 0.03, 2.13) and 0.66% (95% CI: 0.44, 0.87), respectively.ConclusionsWe estimate the prevalence of IC/BPS to be 0.87%, which is lower than prior estimates based on survey data, but higher than prior estimates based on administrative data. These potentially represent the most accurate estimates to date, given the broader and more heterogeneous population studied and our novel methodology of combining in-depth chart abstraction with administrative data.https://www.frontiersin.org/articles/10.3389/fpain.2022.925834/fullinterstitial cystitisbladder pain syndromeIC/BPSepidemiologyprevalencesex/gender
spellingShingle Jennifer T. Anger
Kai B. Dallas
Catherine Bresee
Amanda M. De Hoedt
Kamil E. Barbour
Katherine J. Hoggatt
Marc T. Goodman
Jayoung Kim
Jayoung Kim
Stephen J. Freedland
Stephen J. Freedland
Stephen J. Freedland
National prevalence of IC/BPS in women and men utilizing veterans health administration data
Frontiers in Pain Research
interstitial cystitis
bladder pain syndrome
IC/BPS
epidemiology
prevalence
sex/gender
title National prevalence of IC/BPS in women and men utilizing veterans health administration data
title_full National prevalence of IC/BPS in women and men utilizing veterans health administration data
title_fullStr National prevalence of IC/BPS in women and men utilizing veterans health administration data
title_full_unstemmed National prevalence of IC/BPS in women and men utilizing veterans health administration data
title_short National prevalence of IC/BPS in women and men utilizing veterans health administration data
title_sort national prevalence of ic bps in women and men utilizing veterans health administration data
topic interstitial cystitis
bladder pain syndrome
IC/BPS
epidemiology
prevalence
sex/gender
url https://www.frontiersin.org/articles/10.3389/fpain.2022.925834/full
work_keys_str_mv AT jennifertanger nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT kaibdallas nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT catherinebresee nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT amandamdehoedt nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT kamilebarbour nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT katherinejhoggatt nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT marctgoodman nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT jayoungkim nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT jayoungkim nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT stephenjfreedland nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT stephenjfreedland nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata
AT stephenjfreedland nationalprevalenceoficbpsinwomenandmenutilizingveteranshealthadministrationdata